GlassScriptPhysician profile
Tarra Wilson
NPI 1902164775
$858.43
in general payments reported to CMS, 2019-2025
17 companies · $513 in 2025
The $513 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $152 · 2024: $193 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $158.75 | 2024-2025 | Airsupra, Breztri |
| Abbvie INC. | $128.82 | 2023-2025 | |
| Lilly USA, LLC | $122.80 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $61.38 | 2023-2024 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $52.77 | 2023-2025 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $40.44 | 2023-2025 | Voquezna |
| Axsome Therapeutics, INC. | $39.49 | 2025 | Auvelity |
| Pfizer INC. | $38.94 | 2024-2025 | |
| Abbott Laboratories | $38.46 | 2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $36.27 | 2024-2025 | Trintellix |
| Exact Sciences Corporation | $31.89 | 2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $21.44 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $18.88 | 2023 | |
| Philips North America LLC | $18.16 | 2024 | (Ck7) Extended Holter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.15 | 2024 | Xifaxan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.18 | 2025 | Camzyos |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.61 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarra Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.